Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Flow Neuroscience Launches At-Home, FDA-Approved Brain Stimulation Device For ...

12 September 2026 · By · Wire by Fusion42

Published

12 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at insights.citeline.com →

◆ Verified

Fusion42 · 12 September 2026 · Fusion42 review

Flow Neuroscience has launched an FDA-approved brain stimulation device for at-home treatment of depression in the United States, marking a regulatory and market access milestone.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 10 Sep 2026 and 12 Sep 2026.

◆ ◆ The Wire takeaway

The FDA approval opens US market access for your home-use depression device, shifting the compliance barrier to a commercial opportunity you can pursue immediately.

◆ Coverage

2 sources · first reported 10 Sep 2026 · latest 12 Sep 2026

◆ Related on Wire

◆ Topics

Medtechfda-approvalbrain-stimulationdepression-treatmenthome-usemedical-device